You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥股份(600511.SH):國藥科技擬獲增資1500萬元 同時引入新股東
格隆匯 10-23 16:35

格隆匯10月23日丨國藥股份(600511.SH)公佈,公司控股子公司國藥集團北京醫療科技有限公司(以下簡稱“國藥科技”)擬進行增資擴股,註冊資本由500萬元增資到2000萬元。

公司擬對國藥科技增資,增資後保持50%的持股比例不變;北京若華醫療器械有限公司(以下簡稱“北京若華”)擬對國藥科技增資,增資後持股比例由30%下降到15%;國潤醫療供應鏈服務(上海)有限公司(以下簡稱“國潤醫療”)不參與本次增資,持股比例由20%稀釋到5%。

除國潤醫療外,公司和北京若華擬增資同時擬引進1家摘牌方作為新進股東,摘牌方增資後佔國藥科技股權比例為30%,尚無法確定摘牌方,暫不構成關聯交易。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account